Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder)

Hormones and Behavior

Volumn 54, Issue 1, 2008, Pages 185-193

  Reed, Stephanie Collins ^a   Levin, Frances R ^a   Evans, Suzette M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cognitive performance; Food; Mood; PMDD; Women

Indexed keywords

FAT;

ADULT; APPETITE; ARTICLE; CALORIE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FAT INTAKE; FEMALE; FOLLICULAR PHASE; FOOD INTAKE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; MOOD CHANGE; MOTOR COORDINATION; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; TASK PERFORMANCE;

ADULT; AFFECT; APPETITE; COGNITION; DEPRESSIVE DISORDER; ESTRADIOL; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MEMORY; MENSTRUAL CYCLE; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PREMENSTRUAL SYNDROME; QUESTIONNAIRES; TASK PERFORMANCE AND ANALYSIS;

EID: 43949100980     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2008.02.018     Document Type: Article

References (75)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (1994), Department of Health and Human Services, Washington, DC, U.S.
2. Bancroft J., Williamson L., Warner P., Rennie D., and Smith S.K. Perimenstrual complaints in women complaining of PMS, menorrhagia, and dysmenorrhea: toward a dismantling of the premenstrual syndrome. Psychosom. Med. 55 (1993) 133-145
3. Beck A.T., Steer R.A., Ball R., and Ranieri W.F. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J. Pers. Assess. 67 (1996) 588-597
4. Berger C.P., and Presser B. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study. Obstet. Gynecol. 84 (1994) 379-385
5. Bhatia S.C., and Bhatia S.K. Diagnosis and treatment of premenstrual dysphoric disorder. Am. Fam. Phys. 66 (2002) 1239-1248
6. Both-Orthman B., Rubinow D.R., Hoban M.C., Malley J., and Grover G.N. Menstrual cycle phase-related changes in appetite in patients with premenstrual syndrome and in control subjects. Am. J. Psychiatry. 145 (1988) 628-631
7. Bryant M., Truesdale K.P., and Dye L. Modest changes in dietary intake across the menstrual cycle: implications for food intake research. Br. J. Nutr. 96 (2006) 888-894
8. Brzezinski A.A., Wurtman J.J., Wurtman R.J., Gleason R., Greenfield J., and Nader T. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstet. Gynecol. 76 (1990) 296-301
9. Chamberlain S.R., Muller U., Robbins T.W., and Sahakian B.J. Neuropharmacological modulation of cognition. Curr. Opin. Neurol. 19 (2006) 607-612
10. Constant E.L., Adam S., Gillain B., Seron X., Bruyer R., and Seghers A. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression. Depress. Anxiety 21 (2005) 78-89
11. Cross G.B., Marley J., Miles H., and Willson K. Changes in nutrient intake during the menstrual cycle of overweight women with premenstrual syndrome. Br. J. Nutr. 85 (2001) 475-482
12. De Ronchi D., Ujkaj M., Boaron F., Muro A., Piselli M., and Quartesan R. Symptoms of depression in late luteal phase dysphoric disorder: a variant of mood disorder?. J. Affect. Disord. 86 (2005) 169-174
13. Dickerson L.M., Mazyck P.J., and Hunter M.H. Premenstrual syndrome. Am. Fam. Phys. 67 (2003) 1743-1752
14. Diener D., Greenstein F.L., and Turnbough P.D. Cyclical variation in digit-span and visual-search performance in women differing in the severity of their premenstrual symptoms. Percept. Mot. Skills 74 (1992) 67-76
15. Di Giulio G., and Reissing E.D. Premenstrual dysphoric disorder: prevalence, diagnostic considerations, and controversies. J. Psychosom. Obstet. Gynaecol. 27 (2006) 201-210
16. Dye L., and Blundell J.E. Menstrual cycle and appetite control: implications for weight regulation. Hum. Reprod. 12 (1997) 1142-1151
17. Endicott J., Nee J., Cohen J., and Halbreich U. Premenstrual changes: patterns and correlates of daily ratings. J. Affect. Disord. 10 (1986) 127-135
18. Eriksson E., Hedberg M.A., Andersch B., and Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12 (1995) 167-176
19. Evans S.M., Troisi II J.R., and Griffiths R.R. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans. J. Pharmacol. Exp. Ther. 271 (1994) 683-694
20. Evans S.M., Haney M., Levin F.R., Foltin R.W., and Fischman M.W. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharmology 19 (1998) 499-516
21. Evans S.M., Foltin R.W., and Fischman M.W. Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder. Appetite 32 (1999) 331-349
22. Evans S.M., Levin F.R., and Fischman M.W. Increased sensitivity to alprazolam in females with a paternal history of alcoholism. Psychopharmacology 150 (2000) 150-162
23. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV Axis I disorders - Patient Edition (SCID-I/P, version 2.0) Biometrics Research Department (1995), New York State Psychiatric Institute, New York, NY
24. Fogelson D.L. Weight gain during fluoxetine treatment. J. Clin. Psychopharmacol. 11 (1991) 220-221
25. Freeman E.W., Sondheimer S., Weinbaum P.J., and Rickels K. Evaluating premenstrual symptoms in medical practice. Obstet. Gynecol. 65 (1985) 500-505
26. Freeman E.W., Rickels K., Sondheimer S.J., and Polansky M. A double-blind trial of oral progesterone, alprazolam, and placebo in the treatment of severe premenstrual syndrome. JAMA 274 (1995) 51-57
27. Freeman E.W., Rickels K., Sondheimer S.J., and Polansky M. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch. Gen. Psychiatry 56 (1999) 932-939
28. Freeman E.W., Rickels K., Arredondo F., Kao L.C., Pollack S.E., and Sondheimer S.J. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. J. Clin. Psychopharmacol. 19 (1999) 3-8
29. Freeman E.W., Kroll R., Rapkin A., Pearlstein T., Brown C., Parsey K., Zhang P., Patel H., Foegh M., and PMS/PMDD Research Group. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J. Women's Health Gend.-Based Med. 10 (2001) 561-569
30. Futterman L.A., and Rapkin A.J. Diagnosis of premenstrual disorders. J. Reprod. Med. 51 (2006) 349-358
31. Halbreich U., Endicott J., and Schacht S. Premenstrual syndromes: A new instrument for their assessment. J. Psychiatr. Treat. Eval. 4 (1982) 161-164
32. Halbreich U., Rojansky N., and Palter S. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil. Steril. 56 (1991) 1066-1069
33. Haney M., Comer S.D., Fischman M.W., and Foltin R.W. Alprazolam increases food intake in humans. Psychopharmacology 132 (1997) 311-314
34. Haney M., Hart C.L., Vosburg S.K., Nasser J., Bennett A., Zubaran C., and Foltin R.W. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29 (2004) 158-170
35. Haney M., Hart C.L., Vosburg S.K., Comer S.D., Reed S.C., and Foltin R.W. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology 197 (2008) 157-168
36. Harvey B.H., and Bouwer C.D. Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clin. Neuropharmacol. 23 (2000) 90-97
37. Keenan P.A., Lindamer L.A., and Jong S.K. Psychological aspects of premenstrual syndrome. II: utility of standardized measures. Psychoneuroendocrinology 17 (1992) 189-194
38. Keenan P.A., Stern R.A., Janowsky D.S., and Pedersen C.A. Psychological aspects of premenstrual syndrome I: cognition and memory. Psychoneuroendocrinology. 17 (1992) 179-187
39. Keenan P.A., Lindamer L.A., and Jong S.K. Menstrual phase - independent retrieval deficit in women with PMS. Biol. Psychiatry 38 (1995) 369-377
40. Kelly T.H., Foltin R.W., King L., and Fischman M.W. Behavioral response to diazepam in a residential laboratory. Biol. Psychiatry 31 (1992) 808-822
41. Landen M., Nissbrandt H., Allgulander C., Sorvik K., Ysander C., and Eriksson E. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Neuropsychopharmacology 32 (2007) 153-161
42. Little R.J.A., and Rubin D.B. Statistical analysis with missing data (1987), John Wiley Press, New York
43. Maddocks S., Hahn P., Moller F., and Reid R.L. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am. J. Obstet. Gynecol. 154 (1986) 573-581
44. Man M.S., MacMillan I., Scott J., and Young A.H. Mood, neuropsychological function and cognitions in premenstrual dysphoric disorder. Psychol. Med. 29 (1999) 727-733
45. Martini M.C., Lampe J.W., Slavin J.L., and Kurzer M.S. Effect of the menstrual cycle on energy and nutrient intake. Am. J. Clin. Nutr. 60 (1994) 895-899
46. McLaren D.S. Nutrition and its disorders, 2nd ed (1976), Churchill Livingstone, New York
47. McLeod D.R., Foster G.V., Hoehn-Saric R., Svikis D.S., and Hipsley P.A. Family history of alcoholism in women with generalized anxiety disorder who have premenstrual syndrome: patient reports of premenstrual alcohol consumption and symptoms of anxiety. Alcohol Clin. Exp. Res. 18 (1994) 664-670
48. McNair D., Lorr M., and Droppleman L.F. Profile of Mood States (1971), Educational and Industrial Testing Services, San Diego
49. Mello N.K., Mendelson J.H., and Lex B.W. Alcohol use and premenstrual symptoms in social drinkers. Psychopharmacology. 101 (1990) 448-455
50. Miller T.P., Taylor J.L., and Tinklenberg J.R. A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics. Neuropsychobiology. 19 (1988) 90-96
51. Morgan M., and Rapkin A. Cognitive flexibility, reaction time, and attention in women with premenstrual dysphoric disorder. J. Gend.-Specif. Med. 5 (2002) 28-36
52. Morton J.H., Additon H., Addison R.G., Hunt L., and Sullivan J.J. A clinical study of premenstrual tension. Am. J. Obstet. Gynecol. 65 (1953) 1182-1191
53. Podolsky E. The woman alcoholic and premenstrual tension. J. Am. Med. Women's Assoc. 18 (1963) 816-818
54. Posthuma B.W., Bass M.H., Shelley B.B., and Nisker J.A. Detecting changes in functional ability in women with premenstrual syndrome. Am. J. Obstet. Gynecol. 156 (1987) 275-278
55. Price W.A., DiMarzio L.R., and Eckert J.L. Correlation between PMS and alcoholism among women. Ohio Med. 83 (1987) 201-202
56. Rapkin A.J. The role of serotonin in premenstrual syndrome. Clin. Obstet. Gynecol. 35 (1992) 629-636
57. Rapkin A. A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder. Psychoneuroendocrinology 28 (2003) 39-53
58. Rapkin A.J., Chang L.C., and Reading A.E. Mood and cognitive style in premenstrual syndrome. Obstet. Gynecol. 74 (1989) 644-649
59. Redei E., and Freeman E.W. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 20 (1995) 259-267
60. Resnick A., Perry W., Parry B., Mostofi N., and Udell C. Neuropsychological performance across the menstrual cycle in women with and without premenstrual dysphoric disorder. Psychiatry Res. 77 (1998) 147-158
61. Rubin D.B., and Schenker N. Multiple imputation in health-care data bases: an overview and some applications. Stat. Med. 10 (1991) 585-598
62. Rubinow D.R., Hoban M.C., Grover G.N., Galloway D.S., Roy-Byrne P., Andersen R., and Merriam G.R. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am. J. Obstet. Gynecol. 158 (1988) 5-11
63. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28 (2003) 139-168
64. Sampson G.A. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo. Br. J. Psychiatry 135 (1979) 209-215
65. Schmitt J.A., Jorissen B.L., Dye L., Markus C.R., Deutz N.E., and Riedel W.J. Memory function in women with premenstrual complaints and the effect of serotonergic stimulation by acute administration of an alpha-lactalbumin protein. J. Psychopharmacol. 19 (2005) 375-384
66. Seippel L., and Bäckström T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 83 (1998) 1988-1992
67. Smith S.L., and Sauder C. Food cravings, depression, and premenstrual problems. Psychosom. Med. 31 (1969) 281-287
68. Spielberger C.D., Gorsuch R.L., and Lushene R.E. STAI Manual for the State-Trait Anxiety Inventory ("Self-Evaluation Questionnaire") (1970), Consulting Psychologists Press, Inc, Palo Alto, CA
69. Steiner M., Steinberg S., Stewart D., Carter D., Berger C., Reid R., Grover D., and Streiner D. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N. Engl. J. Med. 332 (1995) 1529-1534
70. Su T.P., Schmidt P.J., Danaceau M.A., Tobin M.B., Rosenstein D.L., Murphy D.L., and Rubinow D.R. Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology 16 (1997) 346-356
71. Thorndike E.L., and Lorge I. The Teacher's Word Book of 30,000 Words (1944), Columbia University, NY Teachers College
72. Tobin M.B., Schmidt P.J., and Rubinow D.R. Reported alcohol use in women with premenstrual syndrome. Am. J. Psychiatry 151 (1994) 1503-1504
73. Wittchen H.U., Becker E., Lieb R., and Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol. Med. 32 (2002) 119-132
74. Wurtman J.J., Brzezinski A., Wurtman R.J., and Laferrere B. Effect of nutrient intake on premenstrual depression. Am. J. Obstet. Gynecol. 161 (1989) 1228-1234
75. Yonkers K.A., Halbreich U., Freeman E., Brown C., and Pearlstein T. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol. Bull. 32 (1996) 41-46